Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck

Lori J. Wirth, Robert I. Haddad, Neal I. Lindeman, Xiaojun Zhao, Jeffrey C. Lee, Victoria A. Joshi, Charles M. Norris, Marshall R. Posner

Research output: Contribution to journalArticlepeer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science